Search results
Bristol Myers' Flagship Opdivo Shows Long Term Durable Benefits In Lung Cancer Patients
Benzinga via Yahoo Finance· 1 year agoBristol Myers Squibb & Co (NYSE: BMY) announced three-year follow-up results from the Phase 3...
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
Zacks via Yahoo Finance· 11 months agoBristol Myers' (BMY) Opdivo, in combination with chemotherapy, gains European Commission approval...